Redhill Biopharma (RDHL) vs Xenetic Biosciences (XBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($5.1 million vs $5.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | RDHL | XBIO |
|---|---|---|
| Share price | $0.578 | $2.12 |
| Market cap | $5.14M | $4.97M |
| 1-day change | +21.94% | -4.07% |
| Forward P/E | 19.27 | — |
| EPS (TTM) | $0.00 | $-1.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.14 | $8.87 |
| 52-week low | $0.435 | $1.87 |
| Distance from 52-week high | -72.99% | -76.10% |
| Average volume | 2.05M | 87.31K |
| Shares outstanding | 8.89M | 2.34M |
| Employees | 13 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 13 employees
About Xenetic Biosciences
XBIO stock →Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance.
Healthcare · Biotechnology · 2 employees
RDHL vs XBIO FAQ
Which is bigger, Redhill Biopharma or Xenetic Biosciences?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $5.14M compared with $4.97M for Xenetic Biosciences (XBIO).
Are Redhill Biopharma and Xenetic Biosciences in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for Redhill Biopharma and Biotechnology for Xenetic Biosciences.